What is the official website of AbbVie ?

The official website of AbbVie is http://www.abbvie.com.

What is AbbVie's cybersecurity risk score?

AbbVie has an AI-generated cybersecurity risk score of 824 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has AbbVie experienced?

According to Rankiteo, AbbVie currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has AbbVie been affected by any supply chain cyber incidents ?

According to Rankiteo, AbbVie has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does AbbVie have SOC 2 Type 1 certification ?

According to Rankiteo, AbbVie is not certified under SOC 2 Type 1.

Does AbbVie have SOC 2 Type 2 certification ?

According to Rankiteo, AbbVie does not hold a SOC 2 Type 2 certification.

Does AbbVie comply with GDPR ?

According to Rankiteo, AbbVie is not listed as GDPR compliant.

Does AbbVie have PCI DSS certification ?

According to Rankiteo, AbbVie does not currently maintain PCI DSS compliance.

Does AbbVie comply with HIPAA ?

According to Rankiteo, AbbVie is not compliant with HIPAA regulations.

Does AbbVie have ISO 27001 certification ?

According to Rankiteo,AbbVie is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does AbbVie operate in ?

AbbVie operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does AbbVie have ?

AbbVie employs approximately 60,650 people worldwide.

Does AbbVie own any subsidiaries ?

AbbVie presently has no subsidiaries across any sectors.

How many LinkedIn followers does AbbVie have ?

AbbVie's official LinkedIn profile has approximately 1,854,042 followers.

What is the NAICS classification code for AbbVie ?

AbbVie is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does AbbVie have a Crunchbase profile ?

Yes, AbbVie has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/abbvie.

Does AbbVie have a LinkedIn profile ?

Yes, AbbVie maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/abbvie.

How many cybersecurity incidents has AbbVie experienced ?

As of June 12, 2026, Rankiteo reports that AbbVie has experienced 2 cybersecurity incidents.

How many peer or competitor companies does AbbVie have ?

AbbVie has an estimated 5,685 peer or competitor companies worldwide.

What types of cybersecurity incidents has AbbVie faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

AbbVie

Boost Score +25 with badge (5 left)

824

/1000

Good

849

/1000

Good

AbbVie Vendor Cyber Rating & Cyber Score

abbvie.com

cb in

Add Your Compliance Badge

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

AbbVie A.I CyberSecurity Scoring

Scoring History

AbbVie

AbbVie CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

AbbVie

Vulnerability

100

4/2026

EGAABB177565877...

AbbVie

Breach

100

6/2023

ABB0473723

Loading…

A.I.

AbbVie Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for AbbVie

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

AbbVie has 40.12% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs All-Companies Average (This Year)

AbbVie has 6.54% fewer incidents than the average of all companies with at least one recorded incident.

Incident Types AbbVie vs Pharmaceutical Manufacturing Industry Avg (This Year)

AbbVie reported 1 incidents this year: 0 cyber attacks, 0 ransomware, 1 vulnerabilities, 0 data breaches, compared to industry peers with at least 1 incident.

Incident History - AbbVie (X = Date, Y = Severity)

Loading…

SUBSIDIARY

AbbVie Subsidiaries

AbbVie

Pharmaceutical Manufacturing

Website: http://www.abbvie.com

Company Size: 10,001+ employees

Allergan Aesthetics, an AbbVie CompanyPharmaceutical Manufacturing

Allergan Medical InstitutePharmaceutical Manufacturing

BOTOX® Cosmetic (onabotulinumtoxinA)Pharmaceutical Manufacturing

Allergan Aesthetics Plastic and Regenerative Medicine PortfolioMedical Equipment Manufacturing

Natrelle Breast ImplantsPharmaceutical Manufacturing

AbbVie | OncologyPharmaceutical Manufacturing

AbbVie | DeutschlandPharmaceutical Manufacturing

AbbVie | UKPharmaceutical Manufacturing

AbbVieEyetoEyePharmaceutical Manufacturing

AbbVie Contract ManufacturingPharmaceutical Manufacturing

AbbVie | VirologyPharmaceutical Manufacturing

Loading…

AbbVie Similar Companies

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Loading…

NEWS

AbbVie CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 23, 2026 07:00 AM

AbbVie Escapes Ill. Genetic Privacy Lawsuit

An Illinois federal judge on Friday granted AbbVie summary judgment in a lawsuit claiming it violated the state's genetic privacy law,...

Read Article

March 09, 2026 07:00 AM

1 Momentum Stock to Consider Right Now and 2 We Ignore

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product...

Read Article

March 01, 2026 01:04 PM

Yeman Collier

Scope of work: Collier oversees technology operations for the $5.3 billion system. Since joining in July 2024, he's led efforts to modernize infrastructure,...

Read Article

March 01, 2026 11:16 AM

Laura Schumacher

At biopharmaceutical giant AbbVie, Laura Schumacher leads 700 legal and external affairs department employees who resolve government investigations,...

Read Article

February 20, 2026 07:51 PM

abbv-20251231

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐.

Read Article

February 20, 2026 08:00 AM

AbbVie Inc. SEC 10-K Report

AbbVie Inc., a global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of...

Read Article

February 04, 2026 08:00 AM

Cybersecurity & Privacy Group Of The Year: Covington

Covington & Burling LLP helped Papa John's and Bloomingdale's win circuit court appeals in privacy class actions, helped Delta Air Lines...

Read Article

August 22, 2025 02:51 PM

Rachel James, AbbVie: Harnessing AI for corporate cybersecurity

Close-up of a laptop as AI News caught up with Rachel James, Principal. Share this story:.

Read Article

August 11, 2025 07:00 AM

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-47238

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #133, a normal authenticated user can edit another user's video subtitles because of a lack of authorization. They can upload subtitles, edit their name or delete them. This issue has been patched in version 5.5.3 - #133.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

Impact Score

2.5

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-x468-whmw-c863

CVE-2026-45418

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #132, any authenticated user who can upload videos can add multiple subtitles from different files and change their title (English, Spanish...). The POST /actions/subtitle_edit.php request used to change their title includes a number parameter which is vulnerable to SQL Injection. A boolean-based blind SQL injection can be used to exfiltrate sensitive data. This issue has been patched in version 5.5.3 - #132.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-q233-m544-6jqr

CVE-2026-45060

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #129, the actions/progress_video.php endpoint is vulnerable to blind SQL injection. Any unauthenticated user can exploit the ids parameter to execute SQL queries and exfiltrate sensitive data. This issue has been patched in version 5.5.3 - #129.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-wpq3-gxx7-c76h

CVE-2026-42846

SUMMARY

ClipBucket v5 is an open source video sharing platform. Prior to version 5.5.3 - #140, ClipBucket's Remote Play feature allows any authenticated user to add a video by importing an external URL as the source. Some shell commands are run with the URL as a parameter. The URL is concatenated directly into shell commands without escaping then executed, so any shell metacharacter in the URL is interpreted. This results in arbitrary command execution. This issue has been patched in version 5.5.3 - #140.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

3.9

REFERENCES

https://github.com/MacWarrior/clipbucket-v5/security/advisories/GHSA-hvfx-hxmr-28c7

CVE-2026-6250

SUMMARY

An authenticated format string vulnerability exists in the ONVIF service of Tapo C110 v2 due to improper handling of user-controlled input. Externally controlled data is interpreted as a format string, which can be used to manipulate stack memory, including control flow data such as return addresses. A remote authenticated attacker may redirect execution flow to existing internal functions, triggering an unauthorized factory reset, leading to loss of configuration, deletion of stored credentials and service disruption.

Published

Date2026-06-11

Updated

Date2026-06-11

RISK INFORMATION (Score: )

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:A/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…